Epothilone B Confers Radiation Dose Enhancement in DAB2IP Gene Knock-Down Radioresistant Prostate Cancer Cells
- 15 November 2010
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 78 (4), 1210-1218
- https://doi.org/10.1016/j.ijrobp.2010.06.019
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Downregulation of Human DAB2IP Gene Expression in Prostate Cancer Cells Results in Resistance to Ionizing RadiationCancer Research, 2010
- Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasisProceedings of the National Academy of Sciences, 2010
- DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosisProceedings of the National Academy of Sciences, 2009
- Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical TrialJournal of Urology, 2009
- Epothilones: tubulin polymerization as a novel target for prostate cancer therapyNature Clinical Practice Oncology, 2008
- Two Genome-wide Association Studies of Aggressive Prostate Cancer Implicate Putative Prostate Tumor Suppressor Gene DAB2IPJNCI Journal of the National Cancer Institute, 2007
- Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02Journal of Clinical Oncology, 2003
- Differential Regulation of the Human Gene DAB2IP in Normal and Malignant Prostatic Epithelia: Cloning and CharacterizationGenomics, 2002
- Structural Basis for the Interaction of Tubulin with Proteins and Drugs that Affect Microtubule DynamicsAnnual Review of Cell and Developmental Biology, 2000
- Antimitotic natural products and their interactions with tubulinMedicinal Research Reviews, 1996